The Jan Grimm Lab

The Grimm lab in the Molecular Pharmacology Program focuses on the development of novel and innovative approaches for cancer diagnostics and therapy. These approaches evaluate underlying biology and utilize nanotechnology, chemistry and physics interrogated with modern imaging methods. The lab focuses currently several avenues: (i) the utilization of nanoparticles for cancer therapy; (ii) novel imaging approaches such as Cerenkov and optoacoustic imaging and (iii) the biology of PSMA both in prostate cancer and neovasculature using a tumor-on-chip microfluidic chip system.

Learn more
Jan Grimm, MD, PhD

Jan Grimm, MD, PhD

Professor

Research Focus

Radiologist and Nuclear Medicine physician Jan Grimm develops novel approaches for improved diagnosis, monitoring and therapy of prostate and other cancers.

Education

  • MD, University of Hamburg (Germany)
  • PhD, University of Kiel (Germany)

Lab Members

Selected Achievements
  • 2014- NIH Nagy New Investigator Award
  • 2018- The American Society for Clinical Investigation (ASCI) Member